Publication | Closed Access

Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis

Breast OncologyOncologyP53 MutationsMedicinePromoter HypermethylationBreast TumorsPathologyCancer GenomicsBreast CancerCancer GeneticsMicrorna DetectionCancer BiologyCell BiologyTumor Biology